Ophthalmological issues in the neurofibromatoses

Journal of Pediatric Ophthalmology and Strabismus

Volumn 33, Issue 4, 1996, Pages 255-259

  Korf, Bruce R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFE AU LAIT SPOT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; LENTIGO; MENINGIOMA; NEURILEMOMA; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; REVIEW; SCOLIOSIS; TREATMENT PLANNING; VESTIBULAR NERVE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EYE DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; NEUROFIBROMATOSIS 1; NEUROFIBROMATOSIS 2; VISUAL ACUITY;

EID: 0029950555     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Stumpf D. Consensus Development Conference of Neurofibromatosis. Arch Neurol. 1988;45:575-578.
2. Tong AKF, Fitzpatrick TB. The Skin in Neurofibromatosis. New York, NY: Thieme: 1990:88-98.
3. Korf BR. Diagnostic outcome in children with multiple café au lait spots. Pediatrics. 1992;90:924-927.
4. Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain. 1988;111:1355-1381.
5. Saxena S, Saxena RC. Discrete and confluent Lisch nodules in neurofibromatosis type 1. Ann Ophthalmol. 1994;26:23-24.
6. Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis: Incidence of iris hamartomas. Ophthalmol. 1981;88:348-354.
7. Perry HD. Iris nodules in von Recklinghausen's neurofibromatosis. Arch Ophthalmol. 1982;100:1635-1640.
8. Zehavi C, Romano A, Goodman RM, Iris (Lisch) nodules in neurofibromatosis. Clin Genet. 1986;29:51-55.
9. Flueler U, Boltshauser E, Kilchhofer A. Iris hamartomata as diagnostic criterion in neurofibromatosis. Neuropediatrics. 1986;17:183-185.
10. Lisch K. Ueber Beteiligung der Augen, insbesondere das Vorkommen von Irisknotchen bei der Neurofibromatose (Recklinghausen). Z Augenheil. 1937;93:137-143.
11. Ragge NK, Falk RE, Cohen WE, Murphree AL. Images of Lisch nodules across the spectrum. Eye. 1993;7:95-101.
12. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatrics. 1994;125:63-66.
13. Listernick R, Charrow J, Greenwald M. Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results. J Pediatrics. 1992;121:584-587.
14. Rossi LN, Pastorino G, Scotti G, et al. Early diagnosis of optic glioma in children with neurofibromatosis type 1. Childs Nervous System. 1994;10:426-429.
15. Pascual-Castroviejo I, Martinez Bermejo A, Lopez Martin V, Roche C, Pascual Pascual SI. Optic gliomas in neurofibromatosis type 1 (NF-1). Presentation of 31 cases. Neurologia. 1994;9:173-177.
16. Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP. Von Recklinghausen neurofibromatosis II; incidence of optic gliomata. Ophthalmol. 1984;91:929-935.
17. van der Meulen J. Orbital neurofibromatosis. Clin Plast Surg. 1987;14:123-135.
18. Ferguson VMG, Kyle PM. Orbital plexiform neurofibroma. Br J Ophthalmol. 1993;77:527-528.
19. Fukuta K, Jackson IT. Orbital neurofibromatosis with enophthalmos. Br J Plast Surg. 1993;46:36-38.
20. Jackson IT, Carbonnel A, Potparic Z, Shaw K. Orbitotemporal neurofibromatosis: Classification and treatment. Plast Reconstr Surg. 1993;92:1-11
21. Huson SM, Jones D, Beck L. Ophthalmic manifestations of neurofibromatosis. Br J Ophthalmol. 1987;71:235-238.
22. Martuza RL, Eldridge R. Neurofibromatosis 2. N Engl J Med. 1988;318:684-688.
23. Huson SM, Thrush DC. Central neurofibromatosis. Quart J Med. 1985;55:213-224.
24. Mautner VF, Hazim W, Guthoff R. Ophthahnologic differentiation of various forms of neurofibromatosis. Ophthalmologe. 1993;90:391-393.
25. Pearson-Webb MA, Kaiser-Kupfer MI, Eldridge R. Eye findings in bilateral acoustic (central) neurofibromatosis: Association with presenile lens opacities and cataracts but absence of Lisch nodules. N Engl J Med. 1986;315:1553-1554.
26. Bouzas EA, Freidlin V, Parry DM, Eldridge R, Kaiser-Kupfer MI. Lens opacities in neurofibromatosis 2: further significant correlations. Br J Ophthalmol. 1993;77:354-357.
27. Bouzas EA, Parry DM, Eldridge R, Kaiser-Kupfer MI. Visual impairment in patients with neurofibromatosis 2. Neurology. 1993;43:622-623.
28. Dossetor FM, Landau K, Hoyt WF. Optic disk glioma in neurofibromatosis type 2. Am J Ophthalmol. 1989;108:602-603.
29. Landau K, Dossetor FM, Hoyt WF, Muci-Mendoza R. Retinal hamartoma in neurofibromatosis 2. Arch Ophthalmol. 1990;108:328-329.
30. Carey JC, Laub JM, Hall BD. Penetrance and variability in neurofibromatosis: a genetic study of 60 families. Birth Defects: Original Article Series. 1979;15, No. 56:271-281.
31. Lewis RA. Ocular Features of Neurofibromatosis. New York, NY: Thieme; 1990:80-87.
32. North K, Cochineas C, Tang E, Fagan E. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol. 1994;10:117-123.
33. Kovalic JJ, Grigsby PW, Shepard MJ, Fineberg BB, Thomas PR. Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys. 1990;18:927-932.
34. Capo H, Kupersmith MJ. Efficacy and complications of radiotherapy of anterior visual pathway tumors. Neurol Clin. 1991;9:179-203.
35. Beyer RA, Paden P, Sobel DF, Flynn FG. Moyamoya pattern of vascular occlusion after radiotherapy for glioma of the optic chiasm. Neurology. 1986;36:1173-1178.
36. Kestle JEW, Hoffman HJ, Mock AR. Moyamoya phenomenon after radiation for optic glioma. J Neurosurg. 1993;79:32-35.
37. Rosenstock JG, Packer RJ, Bilaniuk L, et al. Chiasmatic optic glioma treated with chemotherapy: a preliminary report. J Neurosurg. 1985;63:862-866.
38. Mulliken JB. Plastic Surgery in Neurofibromatosis. New York, NY: Thieme; 1990:111-124.
39. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet. 1994;52:450-461.
40. Gutmann DH, Collins FS. Neurofibromatosis type 1: beyond positional cloning. Arch Neurol. 1993;50:1185-1193.
41. Xu G, Lin B, Tanaka K, et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S cerevisiae. Cell. 1990;63:835-841.
42. Ballester R, Marchuk D, Boguski M, et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 1990;63:851-859.
43. Ruttledge MH, Sarrazin J, Rangaratnam S, et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet. 1994;6-180-184.
44. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993;72:791-800.
45. Seizinger BR, Rouleau G, Ozelius LJ, et al. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science. 1987;236:317-319.
46. Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumous suppressor gene hypothesis. Nat Genet. 1993;3:122-126.
47. MacCollin M, Ramesh V, Jacoby LB, et al. Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet. 1994;55:314-320.